These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1037 related items for PubMed ID: 25839113

  • 1. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation.
    Healy CA, Carrillo RG.
    Heart Rhythm; 2015 Jul; 12(7):1565-73. PubMed ID: 25839113
    [Abstract] [Full Text] [Related]

  • 2. Potential cost-effectiveness of wearable cardioverter-defibrillator for patients with implantable cardioverter-defibrillator explant in a high-income city of China.
    Jiang X, Ming WK, You JHS.
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2387-2396. PubMed ID: 31502350
    [Abstract] [Full Text] [Related]

  • 3. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T, Garisto JD, Salow A, Glad JM, Szymkiewicz S, Saltzman HE, Kutalek SP, Carrillo RG.
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [Abstract] [Full Text] [Related]

  • 4. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ.
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [Abstract] [Full Text] [Related]

  • 5. Wearable cardioverter-defibrillators in pediatric cardiomyopathy: A cost-utility analysis.
    Evers PD, Anderson JB, Ryan TD, Czosek RJ, Knilans TK, Spar DS.
    Heart Rhythm; 2020 Feb; 17(2):287-293. PubMed ID: 31476408
    [Abstract] [Full Text] [Related]

  • 6. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD.
    Kaspar G, Sanam K, Gholkar G, Bianco NR, Szymkiewicz S, Shah D.
    Int J Cardiol; 2018 Dec 01; 272():179-184. PubMed ID: 30121177
    [Abstract] [Full Text] [Related]

  • 7. The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections.
    Castro L, Pecha S, Linder M, Vogler J, Gosau N, Meyer C, Willems S, Reichenspurner H, Hakmi S.
    J Cardiothorac Surg; 2017 Nov 25; 12(1):99. PubMed ID: 29178898
    [Abstract] [Full Text] [Related]

  • 8. Cost-minimization analysis of a wearable cardioverter defibrillator in adult patients undergoing ICD explant procedures: Clinical and economic implications.
    Boriani G, Mantovani LG, Cortesi PA, De Ponti R, D'Onofrio A, Arena G, Curnis A, Forleo G, Guerra F, Porcu M, Sgarito G, Botto GL.
    Clin Cardiol; 2021 Nov 25; 44(11):1497-1505. PubMed ID: 34427926
    [Abstract] [Full Text] [Related]

  • 9. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 25; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 10. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, Rhee EK, Solomon SD, Szymkiewicz SJ.
    J Am Coll Cardiol; 2013 Nov 19; 62(21):2000-2007. PubMed ID: 23916930
    [Abstract] [Full Text] [Related]

  • 11. The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Botto GL, Mantovani LG, Cortesi PA, De Ponti R, D'Onofrio A, Biffi M, Capucci A, Casu G, Notarstefano P, Scaglione M, Zanotto G, Boriani G, Italian Association of Arrhythmology and Cardiac Pacing (AIAC).
    Int J Cardiol; 2022 Jun 01; 356():12-18. PubMed ID: 35395289
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD, Hlatky MA, Owens DK.
    N Engl J Med; 2005 Oct 06; 353(14):1471-80. PubMed ID: 16207849
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):112-21. PubMed ID: 16814657
    [Abstract] [Full Text] [Related]

  • 14. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.
    Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618
    [Abstract] [Full Text] [Related]

  • 15. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M.
    BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442
    [Abstract] [Full Text] [Related]

  • 16. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.
    Opreanu M, Wan C, Singh V, Salehi N, Ahmad J, Szymkiewicz SJ, Thakur RK.
    J Heart Lung Transplant; 2015 Oct 15; 34(10):1305-9. PubMed ID: 26094085
    [Abstract] [Full Text] [Related]

  • 17. The wearable cardioverter defibrillator as a bridge to implantable defibrillator post myocardial infarction: what do we know?
    Barsheshet A, Vamvouris T, Goldenberg I.
    Expert Rev Med Devices; 2016 Jul 15; 13(7):627-32. PubMed ID: 27333818
    [Abstract] [Full Text] [Related]

  • 18. Comparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA study.
    Higuera L, Holbrook R, Wherry K, Rodriguez DA, Cuesta A, Valencia J, Arcos J, López Gómez A.
    J Med Econ; 2021 Jul 15; 24(1):173-180. PubMed ID: 33471579
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.